Influence ofFCGR3A-158V/F Genotype and Baseline CD20...

Clinical Pharmacokinetics 2017 / 6 Vol. 56; Iss. 6

Influence ofFCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group

Tout, Mira, Gagez, Anne-Laure, Leprêtre, Stéphane, Gouilleux-Gruart, Valérie, Azzopardi, Nicolas, Delmer, Alain, Mercier, Mélanie, Ysebaert, Loïc, Laribi, Kamel, Gonzalez, Hugo, Paintaud, Gilles, Cart
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
56
Language:
english
Journal:
Clinical Pharmacokinetics
DOI:
10.1007/s40262-016-0470-8
Date:
June, 2017
File:
PDF, 1.42 MB
english, 2017
Conversion to is in progress
Conversion to is failed